4 hours GE HealthCare Stock Likely to Rise After FDA Approval of Flyrcado Zacks
GEHC’s Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.
GEHC’s Flyrcado, a first-of-its-kind PET tracer for coronary artery disease, receives FDA approval, expanding diagnostic access and improving patient outcomes.